GreenBone Ortho received approval under the CE Mark for its nature-inspired biomimetic GreenBone Bone Substitute™.
GreenBone’s product is derived from a process that transforms bamboo into a biomimetic bone substitute while preserving architecture that incorporates xylem-transporting channels, which mimic the way blood vessels run through bone. The graft can be shaped by surgeons to achieve the best fit of the osseous defect.
Future development will focus on spinal and other skeletal defects and diseases. GreenBone is expected to support a faster return to a patient’s normal life with their own bone completely regenerated and a significant reduction of health care and social costs.
GreenBone Ortho received approval under the CE Mark for its nature-inspired biomimetic GreenBone Bone Substitute™.
GreenBone's product is derived from a process that transforms bamboo into a biomimetic bone substitute while preserving architecture that incorporates xylem-transporting channels, which mimic the way blood vessels run through...
GreenBone Ortho received approval under the CE Mark for its nature-inspired biomimetic GreenBone Bone Substitute™.
GreenBone’s product is derived from a process that transforms bamboo into a biomimetic bone substitute while preserving architecture that incorporates xylem-transporting channels, which mimic the way blood vessels run through bone. The graft can be shaped by surgeons to achieve the best fit of the osseous defect.
Future development will focus on spinal and other skeletal defects and diseases. GreenBone is expected to support a faster return to a patient’s normal life with their own bone completely regenerated and a significant reduction of health care and social costs.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
